These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 33288414)

  • 1. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.
    Cheng Y; Yue L; Wang Z; Zhang J; Xiang G
    J Diabetes Complications; 2021 Feb; 35(2):107809. PubMed ID: 33288414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress hyperglycemia is associated with disease severity in COVID-19.
    Cheng Y; Yue L; Zhang J; Xiang G
    Endokrynol Pol; 2023; 74(5):528-535. PubMed ID: 37902015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
    Zeng X; Jiang X; Yang L; Pan Y; Li Y
    J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyperglycemia on the immune function of COVID-19 patients with type 2 diabetes mellitus: a retrospective study.
    Wang Y; Yi B; Wang S; Chen X; Wen Z
    PeerJ; 2022; 10():e14570. PubMed ID: 37359706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
    Zhang W; Li C; Xu Y; He B; Hu M; Cao G; Li L; Wu S; Wang X; Zhang C; Zhao J; Xie J; Xu Z; Li Q; Wang G
    Mediators Inflamm; 2021; 2021():8812304. PubMed ID: 33814982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data.
    Zaboli E; Majidi H; Alizadeh-Navaei R; Hedayatizadeh-Omran A; Asgarian-Omran H; Vahedi Larijani L; Khodaverdi V; Amjadi O
    J Med Virol; 2021 Sep; 93(9):5425-5431. PubMed ID: 33945642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes.
    Zhang Q; Wei Y; Chen M; Wan Q; Chen X
    J Diabetes Complications; 2020 Oct; 34(10):107666. PubMed ID: 32636061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
    Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
    Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
    Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
    Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    Ni M; Tian FB; Xiang DD; Yu B
    J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
    Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
    Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
    Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of COVID-19 Patients with Diabetes and Secondary Hyperglycemia.
    Zhou W; Ye S; Wang W; Li S; Hu Q
    J Diabetes Res; 2020; 2020():3918723. PubMed ID: 33062712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study.
    Liu J; Li H; Luo M; Liu J; Wu L; Lin X; Li R; Wang Z; Zhong H; Zheng W; Zhou Y; Jiang D; Tan X; Zhou Z; Peng H; Zhang G
    PLoS One; 2020; 15(11):e0241659. PubMed ID: 33206680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
    Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
    Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients.
    Emiroglu C; Dicle M; Yesiloglu C; Gorpelioglu S; Aypak C
    Endocrine; 2024 May; 84(2):470-480. PubMed ID: 38001321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.